Eyelid margin and meibomian gland orifice region

The eyelid margin and meibomian gland orifice region constitute the anatomical site responsible for the production and delivery of the tear film's lipid layer. The meibomian glands are specialized sebaceous glands embedded in the tarsal plates that secrete meibum through orifices located just posterior to the eyelashes (Knop et al., 2011, Investigative Ophthalmology & Visual Science). This lipid secretion is vital for reducing the surface tension of the tear film and preventing the evaporation of the underlying aqueous layer (Nelson et al., 2011, Investigative Ophthalmology & Visual Science). Pathological changes in this region, such as ductal obstruction or inflammation, result in Meibomian Gland Dysfunction (MGD), which is a leading cause of evaporative dry eye disease (StatPearls, 2023). While not a single molecular target, this region is the primary focus for various topical pharmacological interventions. Therapeutic strategies include the use of topical anti-inflammatories like Cyclosporine and novel lubricants such as Perfluorohexyloctane, which mimics the function of natural meibum to stabilize the ocular surface (FDA, 2023). Additionally, antibiotics like Azithromycin are often applied to this region to manage bacterial flora and reduce lipase-mediated lipid degradation (PubMed, 2021).

Other names

Lid marginMeibomian gland openingsPosterior eyelid marginMeibomian gland ductal orifices

Pharmacological interventions at the eyelid margin and meibomian gland orifices aim to reduce ductal inflammation, decrease bacterial lipase activity, improve the viscosity and flow of meibum, and provide a physical barrier to prevent tear film evaporation.